2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells

被引:6
|
作者
Singh, Supriya [1 ]
Saxena, Anil K. [1 ]
机构
[1] Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
关键词
Hsp90 Inhibitor; Purine Derivative; Molar Refractivity; Physiochemical Parameter; Trimethoxyphenyl;
D O I
10.1007/s00044-007-9064-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The chaperone heat shock protein 90 (Hsp90) is an emerging target for designing anticancer agent due to its important roles in maintaining transformation and modulating the survival and growth potential of cancer cells. Quantitative structure-activity relationship (QSAR) studies have been carried out in a series of purine derivatives with Hsp90 inhibitory activities. The two-diemensional (2D) QSAR studies revealed that the activity is positively influenced by the presence of a halo substituent in the trimethoxyphenyl moiety and by electronic parameter (field effect) of the 9-N substituent where the contribution of the steric parameter (MR) is negative. The best QSAR model with good correlation coefficient (r(2) = 0.738), of high statistical significance (> 99.9%) well explained the variance in activity.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 50 条
  • [41] Eco-friendly synthesis and 2D-QSAR study of novel pyrazolines as potential anticolon cancer agents
    Farghaly, Thoraya A.
    Hassaneen, Huwaida M. E.
    Elzahabi, Heba S. A.
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (02) : 652 - 668
  • [42] Hsp90 inhibitor gedunin causes apoptosis in A549 lung cancer cells by disrupting Hsp90:Beclin-1:Bcl-2 interaction and downregulating autophagy
    Hasan, Adria
    Haque, Ejazul
    Hameed, Rohil
    Maier, Paul N.
    Irfan, Safia
    Kamil, Mohd
    Nazir, Aamir
    Mir, Snober S.
    LIFE SCIENCES, 2020, 256
  • [43] Modulation of heat-shock protein 90 (HSP90) client protein expression in prostate cancer cells by a novel novobiocin analog
    Goetzl, MA
    Blagg, BS
    Cronk, B
    Neckers, L
    Holzbeierlein, JM
    JOURNAL OF UROLOGY, 2006, 175 (04): : 140 - 140
  • [44] SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation
    Hamamoto, Ryuji
    Toyokawa, Gouji
    Nakakido, Makoto
    Ueda, Koji
    Nakamura, Yusuke
    CANCER LETTERS, 2014, 351 (01) : 126 - 133
  • [45] The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells
    Peng, Ruixian
    Li, Zhenyu
    Lin, Zhiyuan
    Wang, Yang
    Wang, Wei
    Hu, Bo
    Wang, Xilong
    Zhang, Jun
    Wang, Yangyun
    Zhou, Renyuan
    Lu, Chunhua
    Shen, Yuemao
    Wang, Jifeng
    Shi, Guowei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (10): : 3198 - 3209
  • [46] Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo
    Stoeltzing, Oliver
    Moser, Christian
    Lang, Sven A.
    Lundgren, Karen
    Schlitt, Hans J.
    Zhang, Hong
    Burrows, Francis
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3582S - 3583S
  • [47] The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining
    Lee, Younghyun
    Li, Huizi Keiko
    Masaoka, Aya
    Sunada, Shigeaki
    Hirakawa, Hirokazu
    Fujimori, Akira
    Nickoloff, Jac A.
    Okayasu, Ryuichi
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (01) : 162 - 168
  • [48] Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells
    Eskew, Jeffery D.
    Sadikot, Takrima
    Morales, Pedro
    Duren, Alicia
    Dunwiddie, Irene
    Swink, Megan
    Zhang, Xiaoying
    Hembruff, Stacey
    Donnelly, Alison
    Rajewski, Roger A.
    Blagg, Brian S. J.
    Manjarrez, Jacob R.
    Matts, Robert L.
    Holzbeierlein, Jeffrey M.
    Vielhauer, George A.
    BMC CANCER, 2011, 11
  • [49] Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells
    Wei, Qun
    Ning, Jun-Ya
    Dai, Xi
    Gao, Yuan-Di
    Su, Le
    Zhao, Bao-Xiang
    Miao, Jun-Ying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 145 : 551 - 558
  • [50] Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells
    Jeffery D Eskew
    Takrima Sadikot
    Pedro Morales
    Alicia Duren
    Irene Dunwiddie
    Megan Swink
    Xiaoying Zhang
    Stacey Hembruff
    Alison Donnelly
    Roger A Rajewski
    Brian SJ Blagg
    Jacob R Manjarrez
    Robert L Matts
    Jeffrey M Holzbeierlein
    George A Vielhauer
    BMC Cancer, 11